Study to Investigate Benefits of Weight Loss in Young Adults and Adolescents
Completed · Not applicable
Conditions studied: Obesity, Insulin Resistance
In brief
The purpose of this study is to investigate the changes in subcutaneous adipocyte size, number and gene expression after weight loss and to assess whether those changes contribute to decreases in ectopic fat accumulation and insulin resistance in women between ages of 16-32.
Key facts
- Study ID
- NCT01901978
- Run by
- Yale University
- People needed
- 14
- Starts
- 2011-05-01
- Expected to finish
- 2018-08-01
- Last updated by the study team
- 2020-03-02
Who can join
Age: 16 and older, up to 32. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Women ages 16-32
You may not qualify if…
- They will not be on any medications that are known to alter glucose or insulin metabolism, such as oral steroids, or certain psychiatric medications, such as Xeleca, Lithium and Paxil. Patients on diuretics will be excluded.
Where it is running
- Yale University — New Haven, Connecticut, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.